Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm

CYTAR: A randomized clinical trial evaluating the preventive effect of doxycycline on erlotinib-induced folliculitis in non-small cell lung cancer patients.

(2017) G. Deplanque et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

(2011) Mario E. Lacouture et al.   SUPPORTIVE CARE IN CANCER

Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion

(2010) K. Potthoff et al.   ANNALS OF ONCOLOGY

Skin Toxicity Evaluation Protocol With Panitumumab (STEPP), a Phase II, Open-Label, Randomized Trial Evaluating the Impact of a Pre-Emptive Skin Treatment Regimen on Skin Toxicities and Quality of Life in Patients With Metastatic Colorectal Cancer

(2010) Mario E. Lacouture et al.   JOURNAL OF CLINICAL ONCOLOGY

Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib

(2010) Theognosia Vergou et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Aprepitant for Erlotinib-Induced Pruritus

(2010) Bruno Vincenzi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Staphylococcus Coagulase-Positive Skin Inflammation Associated with Epidermal Growth Factor Receptor-Targeted Therapy: An Early and a Late Phase of Papulopustular Eruptions

(2010) I. Amitay-Laish et al.   ONCOLOGIST

A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group

(2010) Mario E. Lacouture et al.   SUPPORTIVE CARE IN CANCER

MANAGEMENT OF SKIN RASH DURING EGFR-TARGETED MONOCLONAL ANTIBODY TREATMENT FOR GASTRO INTESTINAL MALIGNANCIES: CANADIAN RECOMMENDATIONS

(2009) Barb Melosky et al.   Current Oncology

Biothérapies ciblées en cancérologie digestive : prise en charge de leurs effets secondaires

(2009) O. Bouché et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

A prospective randomized trial of topical pimecrolimus for cetuximab-associated acne-like eruption

(2009) Alon Scope et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

EGFR Inhibitor-Associated Acneiform Folliculitis

(2008) Madeleine Duvic   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY

Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes

(2008) Aminah Jatoi et al.   CANCER